Direct and indirect effects of nicotine/smoking on cognition in humans

Addictive Behaviors

Volumn 25, Issue 1, 2000, Pages 29-43

  Waters, Andrew J ^a   Sutton, Stephen R ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Attention; Cognition; Nicotine; Smoking

Indexed keywords

MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR BLOCKING AGENT;

AROUSAL; ARTICLE; COGNITION; HUMAN; MOOD; SMOKING;

AFFECT; AROUSAL; ATTENTION; COGNITION; HUMANS; NICOTINE; SMOKING;

EID: 0033979280     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4603(99)00023-4     Document Type: Article

References (83)

1. Callaway E., Halliday R., Naylor H. Cholinergic activity and constraints on information processing. Biological Psychology. 33:1992;1-22.
2. Cepeda-Benito A., Tiffany S.T. The use of a dual-task procedure for the assessment of cognitive effort associated with smoking urges. Psychopharmacology. 127:1996;155-163.
3. Curran H.V. Benzodiazepines, memory and mood. A review Psychopharmacology. 105:1991;1-8.
4. Dawe S., Gerada C., Russell M.A.H., Gray J.A. Nicotine intake in smokers increases following a single dose of haloperidol. Psychopharmacology. 117:1995;110-115.
5. Duka T., Curran H.V., Rusted J.M., Weingartner H.J. Perspectives on cognitive psychopharmacology research. Behavioural Pharmacology. 7:1996;401-410.
6. Dunn J.C., Kirsner K. Discovering functionally independent mental processes. The principle of reversed association Psychological Review. 95:1988;91-101.
7. Easterbrook J.A. The effect of emotion on cue utilization and the organization of behaviour. Psychological Review. 66:1959;183-201.
8. Eissenberg T., Griffiths R.R., Stitzer M.L. Mecamylamine does not precipitate withdrawal in cigarette smokers. Psychopharmacology. 127:1996;328-336.
9. Eysenck H.J. The causes and effects of smoking. 1980;Maurice Temple Smith, London.
10. Eysenck M.W. Attention and arousal. Cognition and performance:1982;Springer, Berlin.
11. Eysenck M.W., Calvo M.G. Anxiety and performance. The processing efficiency theory Cognition and Emotion. 6:1992;409-434.
12. Foulds J., McSorley K., Sneddon J., Feyerabend C., Jarvis M.J., Russell M.A.H. Effect of subcutaneous nicotine injections on EEG alpha frequency in non-smokers. A placebo-controlled pilot study Psychopharmacology. 115:1994;163-166.
13. Foulds J., Stapleton J., Bell N., Swettenham J., Jarvis M.J., Russell M.A.H. Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers. Drug and Alcohol Dependence. 44:1997;105-115.
14. Foulds J., Swettenham J., Bell N., McSorley K., Stapleton J., Russell M.A.H. Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology. 127:1996;31-38.
15. Gilbert D.G., Estes S.L., Wesler R. Does noise stress modulate effects of smoking/nicotine? Psychopharmacology. 129:1997;382-389.
16. Gilbert D.G., Meliska C.J., Welser R., Estes S.L. Depression, personality, and gender influence EEG, cortisol, beta-endorphin, heart rate, and subjective responses to smoking multiple cigarettes. Personality and Individual Differences. 16:1994;247-264.
17. Gross T., Jarvik M., Rosenblatt M. Nicotine abstinence produces content-specific Stroop interference. Psychopharmacology. 110:1993;333-336.
18. Hartlage S., Alloy L.B., Vazquez C., Dykman B. Automatic and effortful processing in depression. Psychological Bulletin. 113:1993;247-278.
19. Hatsukami D., Fletcher L., Morgan S., Keenan R., Amble P. The effects of varying cigarette deprivation duration on cognitive and performance tasks. Journal of Substance Abuse. 1:1989;407-416.
20. Heishman S.J. What aspects of human performance are truly enhanced by nicotine? Addiction. 93:1998;317-320.
21. Heishman S.J., Taylor R.C., Henningfield J.E. Nicotine and smoking. A review of effects on human performance Experimental Clinical Psychopharmacology. 2:1994;345-395.
22. Hori T., Hayashi M., Oka M., Agari I., Kawabe K., Takagi M. Re-examination of arousing and de-arousing effects of cigarette smoking. Perceptual and Motor Skills. 78:1994;787-800.
23. Jones G.M., Sahakian B.J., Levy R., Warburton D.M., Gray J.A. Effects of acute subcutaneous nicotine on attention, information processing and short term memory in Alzheimer's disease. Psychopharmacology. 108:1992;485-494.
24. Kassel J.D. Smoking and attention. A review and reformulation of the stimulus-filter hypothesis Clinical Psychology Review. 17:1997;451-478.
25. Kassel J.D., Shiffman S. Attentional mediation of cigarette smoking's effect on anxiety. Health Psychology. 16:1997;359-368.
26. Knott V.J. Neurophysiological aspects of smoking behaviour. A neuroelectric perspective British Journal of Addiction. 86:1991;511-515.
27. Knott V.J., Harr A., Lusk-Mikkelsen S. Functional utility of nicotine. Arousal, mood and performance Snel J., Lorist M. Nicotine, caffeine and social drinking. Behaviour and brain function:1998;115-130 Harwood, Amsterdam.
28. Koelega H.S. Stimulant drugs and vigilance performance. A review Psychopharmacology. 111:1993;1-16.
29. Kumari V., Cotter P.A., Checkley S.A., Gray J.A. Effect of acute subcutaneous nicotine on prepulse inhibition of the acoustic startle reflex in healthy male non-smokers. Psychopharmacology. 132:1997;389-395.
30. Le Houezec J., Halliday R., Benowitz N.L., Callaway E., Naylor H., Herzig K. A low dose of subcutaneous nicotine improves information processing in non-smokers. Psychopharmacology. 114:1994;628-634.
31. Levin E.D. Nicotinic systems and cognitive function. Psychopharmacology. 108:1992;417-431.
32. Levin E.D., Wilson W., Rose J.E., McEvoy J. Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology. 15:1996;429-436.
33. Levin E.D., Conners C.K., Sparrow E., Hinton S.C., Erhardt D., Meck W.H., Rose J.E., March D. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology. 123:1996;55-63.
34. Mangan G.L., Golding J. An 'enhancement' model of smoking maintenance? Thornton R.E. Smoking behaviour. Physiological and psychological influences:1978;87-114 Churchill Livingston, Edinburgh.
35. Mogg K., Bradley B. A cognitive-motivational analysis of anxiety. Behaviour Research and Therapy. 36:1998;809-848.
36. Netter P., Hennig J., Huwe S., Olbrich R. Personality related effects of nicotine, mode of application, and expectancies on performance, emotional states, and desire for smoking. Psychopharmacology. 135:1998;52-62.
37. Newhouse P.A., Potter A., Corwin J., Lenox R. Acute nicotinic blockade produces cognitive impairment in normal humans. Psychopharmacology. 108:1992;480-484.
38. Newhouse P.A., Potter A., Lenox R.H. The effects of nicotinic agents on human cognition. Possible therapeutic applications in Alzheimer's and Parkinson's diseases Medicinal Chemistry Research. 2:1993;628-642.
39. Newhouse P.A., Potter A., Corwin J., Lenox R. Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior. Neuropsychopharmacology. 10(2):1994;93-107.
40. Newhouse P., Sunderland T., Narang P., Mellow A.M., Fertig J.B., Landor B.A., Murphy D.L. Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in non-smoking healthy volunteers and patients with Alzheimer's disease. Psychoneuroendocrinology. 15:1990;471-484.
41. Parrott A.C. Stress modulation over the day in cigarette smokers. Addiction. 90:1995;233-244.
42. Paty (1997). The impact of smoking on affect: A field experiment. Unpublished doctoral dissertation, University of Pittsburgh.
43. Perkins K.A. Combined effects of nicotine and alcohol on subjective, behavioral and physiological responses in humans. Addiction Biology. 2:1997;255-267.
44. Perkins, K. A., Benowitz, N., Henningfield, J., Newhouse, P., Pomerleau, O., & Swan, G.(1996). Conference summary: Society for research on nicotine and tobacco. Addiction, 91, 129-144.
45. Perkins K.A., Grobe J.E., Epstein L.H., Caggiula A.R., Stiller R.L. Effects of nicotine on subjective arousal may be dependent on baseline subjective state. Journal of Substance Abuse. 4:1992;131-141.
46. Perkins K.A., Grobe J.E., Epstein L.H., Caggiula A., Stiller R.L., Jacob R.G. Chronic and acute tolerance to subjective effects of nicotine. Pharmacology, Biochemistry and Behavior. 45:1993;375-381.
47. Perkins K.A., Grobe J.E., Fonte C., Breus M. "Paradoxical" effects of smoking on subjective stress versus cardiovascular arousal in males and females. Pharmacology, Biochemistry and Behaviour. 42:1992;301-311.
48. Perkins K.A., Grobe J.E., Fonte C., Goettler J., Caggiula A.R., Reynolds W.A., Stiller R.L., Scierka A., Jacob R.G. Chronic and acute tolerance to subjective, behavioral and cardiovascular effects of nicotine in humans. The Journal of Pharmacology and Experimental Therapeutics. 270:1994;628-638.
49. Perkins K.A., Grobe J.E., Mitchell S.L., Goettler J., Caggiula A.R., Stiller R.L., Scierka A. Acute tolerance to nicotine in smokers. Lack of dissipation within two hours Psychopharmacology. 118:1995;164-170.
50. Pomerleau C.S. Co-factors for smoking and evolutionary psychobiology. Addiction. 92:1997;397-408.
51. Pomerleau C.S., Pomerleau O.F. Euphoriant effects of nicotine in smokers. Psychopharmacology. 108:1992;460-465.
52. Pomerleau C.S., Pomerleau O.F. Euphoriant effects of nicotine. Tobacco Control. 3:1994;374.
53. Pomerleau O.F., Pomerleau C.S. Research on stress and smoking. Progress and problems British Journal of Addiction. 86:1991;599-603.
54. Provost S.C., Woodward R. Effects of nicotine gum on repeated administration of the stroop test. Psychopharmacology. 104:1991;536-540.
55. Rose J.E., Behm F.M., Westman E.C., Levin E.D., Stein R.M., Lane J.D., Ripka G.V. Combined effects of nicotine and mecamylamine in attenuating smoking satisfaction. Experimental and Clinical Psychopharmacology. 2:1994;328-344.
56. Rose J.E., Corrigall W.A. Nicotine self-administration in animals and humans. similarities and differences Psychopharmacology. 130:1997;28-40.
57. Russell J. A circumplex model of affect. Journal of Personality and Social Psychology. 37:1980;345-356.
58. Russell M.A.H. Nicotine intake and its control over smoking. Wonnacott S., Russell M.A.H., Stolerman I.P. Nicotine psychopharmacology. Molecular, cellular, and behavioural aspects:1990;374-418 Oxford University Press, Oxford.
59. Rusted J.M., Graupner L., Tennant A., Warburton D.M. Effortful processing is a requirement for nicotine-induced improvements in memory. Psychopharmacology. 138:1998;362-368.
60. Rusted J.M., Graupner L., Warburton D. Effects of post-trial administration of nicotine on human memory. Evaluating the conditions for improving memory Psychopharmacology. 119:1995;405-413.
61. Sayette M.A., Hufford M.R. Effects of cue-exposure and deprivation on cognitive resources in smokers. Journal of Abnormal Psychology. 103:1994;812-818.
62. Schneider N.G., Lunell E., Olmstead R.E., Fagerstrom K.-O. Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems Clinical Pharmacokinetics. 31:1996;65-80.
63. Sherwood N. Effects of nicotine on human psychomotor performance. Human Psychopharmacology: Clinical and Experimental. 8:1993;155-184.
64. Shiffman S., Engberg J.B., Paty J.A., Perz W.G., Gnys M., Kassel J.D., Hickcox M. A day at a time. Predicting smoking lapse from daily urge Journal of Abnormal Psychology. 106:1997;104-116.
65. Silver A.A., Sanberg P.R. Transdermal nicotine patch and potentiation of haloperidol in Tourette's syndrome. Lancet. 342:1993;182.
66. Snyder F.R., Davis F.C., Henningfield J.E. The tobacco withdrawal syndrome. Performance decrements on a computerized test battery Drug and Alcohol Dependence. 23:1989;259-266.
67. Soria R., Stapleton J.M., Gilson S.F., Sampson-Cone A., Henningfield J.E., London E.D. Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers. Psychopharmacology. 128:1996;221-226.
68. Stolerman I.P. Behavioural pharmacology of nicotine. Multiple mechanisms British Journal of Addiction. 86:1991;533-536.
69. Stolerman I.P., Chandler C.J., Garcha H.S., Newton J.M. Selective antagonism of behavioural effects of nicotine by dihydro-β-erythroidine in rats. Psychopharmacology. 129:1997;390-397.
70. Svensson, T. H., Grenhoff, J., & Engberg, G. (1990). Effect of nicotine on dynamic function of brain catecholamine neurons. In G. Bock & J. Marsh (Eds.), The biology of nicotine dependence (Ciba Foundation Symposium 152, pp. 169-185). Chichester: John Wiley & Sons.
71. Teasdale J.D., Barnard P.J. Affect, cognition and change. Re-modelling depressive thought:1995;Lawrence Erlbaum, Hove.
72. Thayer R.E. The biopsychology of mood and arousal. 1989;Oxford University Press, New York.
73. Tiffany S.T. A cognitive model of drug urges and drug-use behavior. Role of automatic and nonautomatic processes Psychological Review. 97:1990;147-168.
74. The health consequences of smoking. Nicotine addiction. A report of the Surgeon General:1988;Office on Smoking and Health, Washington, DC.
75. Watson D., Tellegen A. Toward a consensual structure of mood. Psychological Bulletin. 98:1985;219-235.
76. Wells A., Matthews G. Attention and emotion. A clinical perspective:1994;Lawrence Erlbaum Associates, Hove.
77. Wesnes K., Warburton D.M. Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology. 82:1984;147-150.
78. West R. Beneficial effects of nicotine. Fact or fiction? Addiction. 88:1993;589-590.
79. West R. Beneficial effects of nicotine. Reprise Addiction. 89:1994;144-146.
80. West R.J., Jarvis M.J. Effects of nicotine on finger tapping rate in non-smokers. Pharmacology, Biochemistry and Behavior. 25:1986;727-731.
81. West R.J., Russell M.A.H. Cardiovascular and subjective effects of smoking before and after 24h abstinence from cigarettes. Psychopharmacology. 92:1987;118-121.
82. Yerkes R.M., Dodson J.D. The relation of strength of stimulus to rapidity of habit formation. Journal of Comparative and Neurological Psychology. 18:1908;459-482.
83. Zwann R.A., Truitt T.P. Smoking urges affect language processing. Experimental and Clinical Psychopharmacology. 6:1998;325-330.